Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury

被引:236
|
作者
Andriessen, Teuntje M. J. C. [1 ]
Jacobs, Bram [1 ]
Vos, Pieter E. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands
关键词
focal traumatic brain injury; diffuse traumatic brain injury; pathophysiology; traumatic axonal injury; excitotoxicity; mitochondria; axonal disconnection; IMPAIRED AXONAL-TRANSPORT; MITOCHONDRIAL PERMEABILITY TRANSITION; INTRAAXONAL NEUROFILAMENT COMPACTION; SPECTRIN BREAKDOWN PRODUCTS; EXCITATORY AMINO-ACIDS; CYTOCHROME-C RELEASE; APOPTOTIC CELL-DEATH; CLOSED-HEAD INJURY; NEURONAL DEATH; CEREBROSPINAL-FLUID;
D O I
10.1111/j.1582-4934.2010.01164.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction Classifying TBI Clinical injury severity Focal injury or diffuse injury Clinical characteristics Coma, confusion and subacute impairments Imaging TBI Focal and diffuse TBI: separate entities? Pathophysiological mechanisms of focal injury The essentials: glutamate and Ca2+ Mitochondria Caspase and calpain Necrosis versus apoptosis Pathophysiological mechanisms of diffuse injury A heterogeneous cascade of changes After axonal disconnection Conclusions Traumatic brain injury (TBI) is a frequent and clinically highly heterogeneous neurological disorder with large socioeconomic consequences. TBI severity classification, based on the hospital admission Glasgow Coma Scale (GCS) score, ranges from mild (GCS 13-15) and moderate (GCS 9-12) to severe (GCS < 8). The GCS reflects the risk of dying from TBI, which is low after mild (similar to 1%), intermediate after moderate (up to 15%) and high (up to 40%) after severe TBI. Intracranial damage can be focal, such as epidural and subdural haematomas and parenchymal contusions, or diffuse, for example traumatic axonal injury and diffuse cerebral oedema, although this distinction is somewhat arbitrary. Study of the cellular and molecular post-traumatic processes is essential for the understanding of TBI pathophysiology but even more to find therapeutic targets for the development of neuroprotective drugs to be eventually used in human beings. To date, studies in vitro and in vivo, mainly in animals but also in human beings, are unravelling the pathological TBI mechanisms at high pace. Nevertheless, TBI pathophysiology is all but completely elucidated. Neuroprotective treatment studies in human beings have been disappointing thus far and have not resulted in commonly accepted drugs. This review presents an overview on the clinical aspects and the pathophysiology of focal and diffuse TBI, and it highlights several acknowledged important events that occur on molecular and cellular level after TBI.
引用
收藏
页码:2381 / 2392
页数:12
相关论文
共 50 条
  • [1] THE PATHOPHYSIOLOGICAL MECHANISMS FOLLOWING TRAUMATIC BRAIN INJURY
    de Andrade, Almir Ferreira
    Paiva, Wellingson Silva
    Oliveira de Amorim, Robson Luis
    Figueiredo, Eberval Gadelha
    Rusafa Neto, Eloy
    Teixeira, Manoel Jacobsen
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2009, 55 (01): : 75 - 81
  • [2] Biomarkers of focal and diffuse traumatic brain injury
    Pieter E Vos
    [J]. Critical Care, 15 (4):
  • [3] Traumatic brain edema in diffuse and focal injury: Cellular or vasogenic?
    Marmarou, A.
    Signoretti, S.
    Ayg, G.
    Fatouros, P.
    Portella, G.
    [J]. BRAIN EDEMA XIII, 2006, 96 : 24 - +
  • [4] Brain tissue oxygenation and cerebral metabolic patterns in focal and diffuse traumatic brain injury
    Purins, Karlis
    Lewen, Anders
    Hillered, Lars
    Howells, Tim
    Enblad, Per
    [J]. FRONTIERS IN NEUROLOGY, 2014, 5
  • [5] Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue
    Sami Abu Hamdeh
    Ganna Shevchenko
    Jia Mi
    Sravani Musunuri
    Jonas Bergquist
    Niklas Marklund
    [J]. Scientific Reports, 8
  • [6] Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue
    Abu Hamdeh, Sami
    Shevchenko, Ganna
    Mi, Jia
    Musunuri, Sravani
    Bergquist, Jonas
    Marklund, Niklas
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [7] PROTEOMIC DIFFERENCES BETWEEN FOCAL AND DIFFUSE TRAUMATIC BRAIN INJURY IN HUMAN BRAIN TISSUE
    Abu Hamdeh, Sami
    Shevchenko, Ganna
    Mi, Jia
    Musunuri, Sravani
    Bergquist, Jonas
    Marklund, Niklas
    [J]. JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A238 - A239
  • [8] Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
    Tanriverdi, Fatih
    Schneider, Harald Joern
    Aimaretti, Gianluca
    Masel, Brent E.
    Casanueva, Felipe F.
    Kelestimur, Fahrettin
    [J]. ENDOCRINE REVIEWS, 2015, 36 (03) : 305 - 342
  • [9] An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms
    Fesharaki-Zadeh, Arman
    Datta, Dibyadeep
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2024, 18
  • [10] Characterisation of endogenous neurogenesis following focal and diffuse models of traumatic brain injury
    Bye, N
    Han, X
    Malakooti, N
    Rosenfeld, J
    Kossmann, T
    Morganti-Kossmann, C
    [J]. JOURNAL OF NEUROTRAUMA, 2006, 23 (05) : 785 - 785